CXCL9 Predicts Severity at the Onset of Chronic Graft-versus-host Disease-Reference-Cited by-同舟云学术

CXCL9 Predicts Severity at the Onset of Chronic Graft-versus-host Disease

Published:2020-02-01 Issue:11 Volume:104 Page:2354-2359
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Giesen Nicola,Schwarzbich Mark-Alexander,Dischinger Katharina,Becker Natalia,Hummel Manuela,Benner Axel,Radujkovic Aleksandar,Müller-Tidow Carsten,Dreger Peter,Luft Thomas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference25 articles.

1. Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the center for international blood and marrow transplant research.;Arai;Biol Blood Marrow Transplant,2015

2. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late effects working committee of the international bone marrow transplant registry.;Socié;N Engl J Med,1999

3. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.;Wingard;J Clin Oncol,2011

4. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.;Filipovich;Biol Blood Marrow Transplant,2005

5. Chronic GVHD is associated with lower relapse risk irrespective of stem cell source among patients receiving transplantation from unrelated donors.;Signori;Bone Marrow Transplant,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic forecasting module for chronic graft-versus-host disease progression based on a disease-specific subpopulation of B cells;2024-04-22

2. Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy?;Pharmaceuticals;2024-02-26

3. Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants;Frontiers in Immunology;2024-02-16

4. EASIX-1year and late mortality after allogeneic stem cell transplantation;Blood Advances;2023-09-15

5. Pretransplantation EASIX Score Predicts Nonrelapse and Overall Mortality of Adult Patients Undergoing Single-Unit Unrelated Cord Blood Transplantation;Transplantation and Cellular Therapy;2023-09